Word from the team

Dear reader,

In this edition of the TTO Newsletter read the story behind the successful EPFL Spin-off Rheon Medical, which is revolutionising the surgical treatment of glaucoma

Have you always wondered why scientific discoveries take long to reach the general public? Did you know that the world's first hybrid robotic surgery took place at the Inselspital in Bern? Check out the Featured news section to read the latest stories on innovation and, hopefully, find answers to your questions.

Finally, do not miss the latest licensing opportunities !

We hope you will enjoy the reading !

Sincerely,

The TTO Team

Rheon Medical is revolutionising the surgical treatment of glaucoma

EPFL spin-off Rheon Medical has developed the world’s first adjustable glaucoma drainage system, which has already been used successfully in over 250 patients in Europe.

The company, based at EPFL Innovation Park, closed a CHF 5.6 million Series C funding round in December 2020 and just received the U.S. FDA’s Breakthrough Device Designation for its technology.

Featured news

• Who owns the discoveries and inventions made by EPFL scientists?

• SOPHiA Genetics set to go public at a $1.1 billion valuation

• Why do scientific discoveries take long to reach the general public?

• Aleva Recruits First Patient into PMCF Study with directSTIM Directional Deep Brain Stimulation System

• The World’s First Hybrid Robotic Surgery Took Place at the Inselspital in Bern

• AC Immune acquires Parkinson’s disease vaccine candidate and equity investment

Latest licensing opportunities

• System for the non-invasive measurement of cardiovascular parameters

• Method for the synthesis of new triazenes

• Systems and Methods for Treating Alzheimer’s disease

• Novel Polymer or polycondensate based on peptide and linker

EPFL Innovation Events

Get in touch?

​ info.tto@epfl.ch

Follow us